Medscape Neurology and Neurosurgery Headlines This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

FDA's New Guidance for Early Alzheimer's Drug Development FDA's New Guidance for Early Alzheimer's Drug Development
The FDA embraces the use of biomarkers and surrogate endpoints in its most recent guidance on developing therapeutics for early Alzheimer ’s disease.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 19, 2024 Category: Neurology Tags: Psychiatry Source Type: news

Adults With Late-Onset MS at High Risk for Rapid Progression Adults With Late-Onset MS at High Risk for Rapid Progression
MS that develops after age 50 tends to progress more rapidly than younger-onset MS and is less apt to respond to disease-modifying therapy, Swedish registry data show.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 15, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Neurologic Disorders Now Top Cause of Illness, Disability Neurologic Disorders Now Top Cause of Illness, Disability
Neurologic conditions are now the leading cause of illness and disability, affecting more than 3 billion people around the world, a comprehensive new analysis showed.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 14, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Neurological Disorders Now Top Cause of Illness, Disability Neurological Disorders Now Top Cause of Illness, Disability
Neurological conditions are now the leading cause of illness and disability, affecting more than 3 billion people around the world, a comprehensive new analysis showed.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 14, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Clemastine Tied to Worsening Symptoms in Multidrug MS Trial Clemastine Tied to Worsening Symptoms in Multidrug MS Trial
Worsening symptoms among several patients with MS taking the OTC antihistamine clemastine prompted investigators to halt that arm of a multidrug trial.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 14, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

An Easy, Effective Solution to Heat Sensitivity in RRMS? An Easy, Effective Solution to Heat Sensitivity in RRMS?
Aspirin and acetaminophen may offer an effective and inexpensive solution to exercise-induced heat sensitivity in relapsing-remitting multiple sclerosis, phase 3 data suggested.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 14, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Obstructive Sleep Apnea Linked to Higher Stroke Risk Obstructive Sleep Apnea Linked to Higher Stroke Risk
Obstructive sleep apnea is linked to a higher risk of incident stroke regardless of CPAP use – but only in White individuals.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 13, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Watchdog Group: Remove ALS Drug Relyvrio From Market Now Watchdog Group: Remove ALS Drug Relyvrio From Market Now
The watchdog group Public Citizen is calling for the prompt removal of the ALS drug Relyvrio after it failed to meet primary and secondary endpoints in top-line results from a phase 3 trial.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 13, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Infant Exposure to MS Drugs via Breastfeeding: New Data Infant Exposure to MS Drugs via Breastfeeding: New Data
Infant exposure to monoclonal antibodies used to treat MS via breast milk does not negatively affect health or development out to 3 years, a new study shows.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 12, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Service Dogs Lead to Fewer Seizures in Resistant Epilepsy Service Dogs Lead to Fewer Seizures in Resistant Epilepsy
Working with a trained service dog is associated with fewer seizures in patients with treatment-resistant epilepsy, new research shows.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 12, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

New Data Support Viagra for Alzheimer ’s Prevention New Data Support Viagra for Alzheimer ’s Prevention
Real-world patient data show a 30%-54% reduced prevalence of Alzheimer ' s disease in patients using the erectile dysfunction drug sildenafil (Viagra).Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 12, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

When Should a Pediatrician Suspect a Rare Disease? When Should a Pediatrician Suspect a Rare Disease?
Common symptoms expressed in an intense or complicated way, or the presence of many symptoms in the same patient, should raise suspicion of rare disease, said one clinician.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 11, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

US FDA Declines to Approve Viatris's Injection for Multiple Sclerosis US FDA Declines to Approve Viatris's Injection for Multiple Sclerosis
The U.S. FDA has declined to approve Viatris and Mapi Pharma ' s once-a-month injection for treating relapsing forms of debilitating neurological condition multiple sclerosis...Reuters Health Information (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 11, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Atogepant for Episodic Migraine Prevention: Phase 3 Data Atogepant for Episodic Migraine Prevention: Phase 3 Data
Results of the ELEVATE trial demonstrating the safety and efficacy of oral atogepant for the prevention of treatment-resistant episodic migraine prevention have now been published.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 8, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Most Disadvantaged Least Likely to Receive Thrombolysis Most Disadvantaged Least Likely to Receive Thrombolysis
Black, male, and older ischemic stroke patients are less likely than other populations to antithrombolytic therapy.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 8, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news